Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size, Status and Forecast 2020-2026

May 2020 | 134 pages | ID: G52783EE38C8EN
QYResearch

Abstracts

This report focuses on the global Point-of-Care Infectious Disease Diagnostics/Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Point-of-Care Infectious Disease Diagnostics/Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Abbott
• Thermo Fisher Scientific Inc
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers
• BD & Company
• Chembio Diagnostics Inc.
• Trinity Biotech
• Cardinal Health
• Quest Diagnostics Inc.
• Bio-Rad Labs Inc.
• bioM?rieux SA
• Sight Diagnostics Ltd.
• Gene POC
• Trivitron Healthcare
• OJ-Bio Ltd.
• Ortho-Clinical Diagnostics

Market segment by Type, the product can be split into

• HIV POC
• Clostridium difficile POC
• HBV POC
• Pneumonia or Streptococcus associated infections
• Respiratory syncytial virus (RSV) POC
• HPV POC
• Influenza/Flu POC
• Other Infectious Disease POC

Market segment by Application, split into

• Hospitals
• Clinics
• Home
• Assisted Living Healthcare Facilities
• Laboratories
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Point-of-Care Infectious Disease Diagnostics/Testing status, future forecast, growth opportunity, key market and key players.
• To present the Point-of-Care Infectious Disease Diagnostics/Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Point-of-Care Infectious Disease Diagnostics/Testing are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Point-of-Care Infectious Disease Diagnostics/Testing Revenue
1.4 Market Analysis by Type
  1.4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 HIV POC
  1.4.3 Clostridium difficile POC
  1.4.4 HBV POC
  1.4.5 Pneumonia or Streptococcus associated infections
  1.4.6 Respiratory syncytial virus (RSV) POC
  1.4.7 HPV POC
  1.4.8 Influenza/Flu POC
  1.4.9 Other Infectious Disease POC
1.5 Market by Application
  1.5.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Home
  1.5.5 Assisted Living Healthcare Facilities
  1.5.6 Laboratories
  1.5.7 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Point-of-Care Infectious Disease Diagnostics/Testing Market Perspective (2015-2026)
2.2 Point-of-Care Infectious Disease Diagnostics/Testing Growth Trends by Regions
  2.2.1 Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Point-of-Care Infectious Disease Diagnostics/Testing Historic Market Share by Regions (2015-2020)
  2.2.3 Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Point-of-Care Infectious Disease Diagnostics/Testing Market Growth Strategy
  2.3.6 Primary Interviews with Key Point-of-Care Infectious Disease Diagnostics/Testing Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Market Size
  3.1.1 Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Revenue (2015-2020)
  3.1.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Players (2015-2020)
  3.1.3 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Concentration Ratio
  3.2.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Point-of-Care Infectious Disease Diagnostics/Testing Revenue in 2019
3.3 Point-of-Care Infectious Disease Diagnostics/Testing Key Players Head office and Area Served
3.4 Key Players Point-of-Care Infectious Disease Diagnostics/Testing Product Solution and Service
3.5 Date of Enter into Point-of-Care Infectious Disease Diagnostics/Testing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Historic Market Size by Type (2015-2020)
4.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Type (2021-2026)

5 POINT-OF-CARE INFECTIOUS DISEASE DIAGNOSTICS/TESTING BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
5.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
6.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in North America (2019-2020)
6.3 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
6.4 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
7.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in Europe (2019-2020)
7.3 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
7.4 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)

8 CHINA

8.1 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
8.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in China (2019-2020)
8.3 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
8.4 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
9.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in Japan (2019-2020)
9.3 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
9.4 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
10.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)

11 INDIA

11.1 India Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
11.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in India (2019-2020)
11.3 India Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
11.4 India Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
12.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
12.4 Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abbott
  13.1.1 Abbott Company Details
  13.1.2 Abbott Business Overview and Its Total Revenue
  13.1.3 Abbott Point-of-Care Infectious Disease Diagnostics/Testing Introduction
  13.1.4 Abbott Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020))
  13.1.5 Abbott Recent Development
13.2 Thermo Fisher Scientific Inc
  13.2.1 Thermo Fisher Scientific Inc Company Details
  13.2.2 Thermo Fisher Scientific Inc Business Overview and Its Total Revenue
  13.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Introduction
  13.2.4 Thermo Fisher Scientific Inc Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
  13.2.5 Thermo Fisher Scientific Inc Recent Development
13.3 F. Hoffmann-La Roche Ltd
  13.3.1 F. Hoffmann-La Roche Ltd Company Details
  13.3.2 F. Hoffmann-La Roche Ltd Business Overview and Its Total Revenue
  13.3.3 F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Introduction
  13.3.4 F. Hoffmann-La Roche Ltd Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
  13.3.5 F. Hoffmann-La Roche Ltd Recent Development
13.4 Siemens Healthineers
  13.4.1 Siemens Healthineers Company Details
  13.4.2 Siemens Healthineers Business Overview and Its Total Revenue
  13.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Introduction
  13.4.4 Siemens Healthineers Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
  13.4.5 Siemens Healthineers Recent Development
13.5 BD & Company
  13.5.1 BD & Company Company Details
  13.5.2 BD & Company Business Overview and Its Total Revenue
  13.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Introduction
  13.5.4 BD & Company Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
  13.5.5 BD & Company Recent Development
13.6 Chembio Diagnostics Inc.
  13.6.1 Chembio Diagnostics Inc. Company Details
  13.6.2 Chembio Diagnostics Inc. Business Overview and Its Total Revenue
  13.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
  13.6.4 Chembio Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
  13.6.5 Chembio Diagnostics Inc. Recent Development
13.7 Trinity Biotech
  13.7.1 Trinity Biotech Company Details
  13.7.2 Trinity Biotech Business Overview and Its Total Revenue
  13.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Introduction
  13.7.4 Trinity Biotech Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
  13.7.5 Trinity Biotech Recent Development
13.8 Cardinal Health
  13.8.1 Cardinal Health Company Details
  13.8.2 Cardinal Health Business Overview and Its Total Revenue
  13.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Introduction
  13.8.4 Cardinal Health Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
  13.8.5 Cardinal Health Recent Development
13.9 Quest Diagnostics Inc.
  13.9.1 Quest Diagnostics Inc. Company Details
  13.9.2 Quest Diagnostics Inc. Business Overview and Its Total Revenue
  13.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
  13.9.4 Quest Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
  13.9.5 Quest Diagnostics Inc. Recent Development
13.10 Bio-Rad Labs Inc.
  13.10.1 Bio-Rad Labs Inc. Company Details
  13.10.2 Bio-Rad Labs Inc. Business Overview and Its Total Revenue
  13.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
  13.10.4 Bio-Rad Labs Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
  13.10.5 Bio-Rad Labs Inc. Recent Development
13.11 bioM?rieux SA
  10.11.1 bioM?rieux SA Company Details
  10.11.2 bioM?rieux SA Business Overview and Its Total Revenue
  10.11.3 bioM?rieux SA Point-of-Care Infectious Disease Diagnostics/Testing Introduction
  10.11.4 bioM?rieux SA Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
  10.11.5 bioM?rieux SA Recent Development
13.12 Sight Diagnostics Ltd.
  10.12.1 Sight Diagnostics Ltd. Company Details
  10.12.2 Sight Diagnostics Ltd. Business Overview and Its Total Revenue
  10.12.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
  10.12.4 Sight Diagnostics Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
  10.12.5 Sight Diagnostics Ltd. Recent Development
13.13 Gene POC
  10.13.1 Gene POC Company Details
  10.13.2 Gene POC Business Overview and Its Total Revenue
  10.13.3 Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Introduction
  10.13.4 Gene POC Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
  10.13.5 Gene POC Recent Development
13.14 Trivitron Healthcare
  10.14.1 Trivitron Healthcare Company Details
  10.14.2 Trivitron Healthcare Business Overview and Its Total Revenue
  10.14.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Introduction
  10.14.4 Trivitron Healthcare Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
  10.14.5 Trivitron Healthcare Recent Development
13.15 OJ-Bio Ltd.
  10.15.1 OJ-Bio Ltd. Company Details
  10.15.2 OJ-Bio Ltd. Business Overview and Its Total Revenue
  10.15.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
  10.15.4 OJ-Bio Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
  10.15.5 OJ-Bio Ltd. Recent Development
13.16 Ortho-Clinical Diagnostics
  10.16.1 Ortho-Clinical Diagnostics Company Details
  10.16.2 Ortho-Clinical Diagnostics Business Overview and Its Total Revenue
  10.16.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Introduction
  10.16.4 Ortho-Clinical Diagnostics Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
  10.16.5 Ortho-Clinical Diagnostics Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Point-of-Care Infectious Disease Diagnostics/Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Point-of-Care Infectious Disease Diagnostics/Testing Revenue
Table 3. Ranking of Global Top Point-of-Care Infectious Disease Diagnostics/Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of HIV POC
Table 6. Key Players of Clostridium difficile POC
Table 7. Key Players of HBV POC
Table 8. Key Players of Pneumonia or Streptococcus associated infections
Table 9. Key Players of Respiratory syncytial virus (RSV) POC
Table 10. Key Players of HPV POC
Table 11. Key Players of Influenza/Flu POC
Table 12. Key Players of Other Infectious Disease POC
Table 13. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Regions (2015-2020)
Table 17. Global Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Point-of-Care Infectious Disease Diagnostics/Testing Market Growth Strategy
Table 23. Main Points Interviewed from Key Point-of-Care Infectious Disease Diagnostics/Testing Players
Table 24. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Players (2015-2020) (Million US$)
Table 25. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Players (2015-2020)
Table 26. Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-Care Infectious Disease Diagnostics/Testing as of 2019)
Table 27. Global Point-of-Care Infectious Disease Diagnostics/Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Point-of-Care Infectious Disease Diagnostics/Testing Product Solution and Service
Table 30. Date of Enter into Point-of-Care Infectious Disease Diagnostics/Testing Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (Million US$)
Table 33. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Share by Type (2015-2020)
Table 34. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Type (2021-2026)
Table 35. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Share by Application (2015-2020)
Table 36. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (Million US$)
Table 37. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Share by Application (2021-2026)
Table 38. North America Key Players Point-of-Care Infectious Disease Diagnostics/Testing Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Point-of-Care Infectious Disease Diagnostics/Testing Market Share (2019-2020)
Table 40. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (Million US$)
Table 41. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
Table 42. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (Million US$)
Table 43. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
Table 44. Europe Key Players Point-of-Care Infectious Disease Diagnostics/Testing Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Point-of-Care Infectious Disease Diagnostics/Testing Market Share (2019-2020)
Table 46. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
Table 48. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
Table 50. China Key Players Point-of-Care Infectious Disease Diagnostics/Testing Revenue (2019-2020) (Million US$)
Table 51. China Key Players Point-of-Care Infectious Disease Diagnostics/Testing Market Share (2019-2020)
Table 52. China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (Million US$)
Table 53. China Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
Table 54. China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (Million US$)
Table 55. China Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
Table 56. Japan Key Players Point-of-Care Infectious Disease Diagnostics/Testing Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Point-of-Care Infectious Disease Diagnostics/Testing Market Share (2019-2020)
Table 58. Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
Table 60. Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Point-of-Care Infectious Disease Diagnostics/Testing Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Point-of-Care Infectious Disease Diagnostics/Testing Market Share (2019-2020)
Table 64. Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
Table 66. Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
Table 68. India Key Players Point-of-Care Infectious Disease Diagnostics/Testing Revenue (2019-2020) (Million US$)
Table 69. India Key Players Point-of-Care Infectious Disease Diagnostics/Testing Market Share (2019-2020)
Table 70. India Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (Million US$)
Table 71. India Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
Table 72. India Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (Million US$)
Table 73. India Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Point-of-Care Infectious Disease Diagnostics/Testing Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Point-of-Care Infectious Disease Diagnostics/Testing Market Share (2019-2020)
Table 76. Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
Table 78. Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
Table 80. Abbott Company Details
Table 81. Abbott Business Overview
Table 82. Abbott Product
Table 83. Abbott Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
Table 84. Abbott Recent Development
Table 85. Thermo Fisher Scientific Inc Company Details
Table 86. Thermo Fisher Scientific Inc Business Overview
Table 87. Thermo Fisher Scientific Inc Product
Table 88. Thermo Fisher Scientific Inc Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
Table 89. Thermo Fisher Scientific Inc Recent Development
Table 90. F. Hoffmann-La Roche Ltd Company Details
Table 91. F. Hoffmann-La Roche Ltd Business Overview
Table 92. F. Hoffmann-La Roche Ltd Product
Table 93. F. Hoffmann-La Roche Ltd Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
Table 94. F. Hoffmann-La Roche Ltd Recent Development
Table 95. Siemens Healthineers Company Details
Table 96. Siemens Healthineers Business Overview
Table 97. Siemens Healthineers Product
Table 98. Siemens Healthineers Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
Table 99. Siemens Healthineers Recent Development
Table 100. BD & Company Company Details
Table 101. BD & Company Business Overview
Table 102. BD & Company Product
Table 103. BD & Company Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
Table 104. BD & Company Recent Development
Table 105. Chembio Diagnostics Inc. Company Details
Table 106. Chembio Diagnostics Inc. Business Overview
Table 107. Chembio Diagnostics Inc. Product
Table 108. Chembio Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
Table 109. Chembio Diagnostics Inc. Recent Development
Table 110. Trinity Biotech Company Details
Table 111. Trinity Biotech Business Overview
Table 112. Trinity Biotech Product
Table 113. Trinity Biotech Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
Table 114. Trinity Biotech Recent Development
Table 115. Cardinal Health Business Overview
Table 116. Cardinal Health Product
Table 117. Cardinal Health Company Details
Table 118. Cardinal Health Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
Table 119. Cardinal Health Recent Development
Table 120. Quest Diagnostics Inc. Company Details
Table 121. Quest Diagnostics Inc. Business Overview
Table 122. Quest Diagnostics Inc. Product
Table 123. Quest Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
Table 124. Quest Diagnostics Inc. Recent Development
Table 125. Bio-Rad Labs Inc. Company Details
Table 126. Bio-Rad Labs Inc. Business Overview
Table 127. Bio-Rad Labs Inc. Product
Table 128. Bio-Rad Labs Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
Table 129. Bio-Rad Labs Inc. Recent Development
Table 130. bioM?rieux SA Company Details
Table 131. bioM?rieux SA Business Overview
Table 132. bioM?rieux SA Product
Table 133. bioM?rieux SA Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
Table 134. bioM?rieux SA Recent Development
Table 135. Sight Diagnostics Ltd. Company Details
Table 136. Sight Diagnostics Ltd. Business Overview
Table 137. Sight Diagnostics Ltd. Product
Table 138. Sight Diagnostics Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
Table 139. Sight Diagnostics Ltd. Recent Development
Table 140. Gene POC Company Details
Table 141. Gene POC Business Overview
Table 142. Gene POC Product
Table 143. Gene POC Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
Table 144. Gene POC Recent Development
Table 145. Trivitron Healthcare Company Details
Table 146. Trivitron Healthcare Business Overview
Table 147. Trivitron Healthcare Product
Table 148. Trivitron Healthcare Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
Table 149. Trivitron Healthcare Recent Development
Table 150. OJ-Bio Ltd. Company Details
Table 151. OJ-Bio Ltd. Business Overview
Table 152. OJ-Bio Ltd. Product
Table 153. OJ-Bio Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
Table 154. OJ-Bio Ltd. Recent Development
Table 155. Ortho-Clinical Diagnostics Company Details
Table 156. Ortho-Clinical Diagnostics Business Overview
Table 157. Ortho-Clinical Diagnostics Product
Table 158. Ortho-Clinical Diagnostics Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
Table 159. Ortho-Clinical Diagnostics Recent Development
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type: 2020 VS 2026
Figure 2. HIV POC Features
Figure 3. Clostridium difficile POC Features
Figure 4. HBV POC Features
Figure 5. Pneumonia or Streptococcus associated infections Features
Figure 6. Respiratory syncytial virus (RSV) POC Features
Figure 7. HPV POC Features
Figure 8. Influenza/Flu POC Features
Figure 9. Other Infectious Disease POC Features
Figure 10. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application: 2020 VS 2026
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Home Case Studies
Figure 14. Assisted Living Healthcare Facilities Case Studies
Figure 15. Laboratories Case Studies
Figure 16. Others Case Studies
Figure 17. Point-of-Care Infectious Disease Diagnostics/Testing Report Years Considered
Figure 18. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 19. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Regions: 2020 VS 2026
Figure 20. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Regions (2021-2026)
Figure 21. Porter's Five Forces Analysis
Figure 22. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Players in 2019
Figure 23. Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-Care Infectious Disease Diagnostics/Testing as of 2019
Figure 24. The Top 10 and 5 Players Market Share by Point-of-Care Infectious Disease Diagnostics/Testing Revenue in 2019
Figure 25. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. China Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. India Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 32. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Abbott Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 34. Thermo Fisher Scientific Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Thermo Fisher Scientific Inc Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 36. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 38. Siemens Healthineers Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Siemens Healthineers Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 40. BD & Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. BD & Company Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 42. Chembio Diagnostics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Chembio Diagnostics Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 44. Trinity Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Trinity Biotech Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 46. Cardinal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Cardinal Health Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 48. Quest Diagnostics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Quest Diagnostics Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 50. Bio-Rad Labs Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Bio-Rad Labs Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 52. bioM?rieux SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. bioM?rieux SA Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 54. Sight Diagnostics Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Sight Diagnostics Ltd. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 56. Gene POC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Gene POC Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 58. Trivitron Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Trivitron Healthcare Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 60. OJ-Bio Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. OJ-Bio Ltd. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 62. Ortho-Clinical Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Ortho-Clinical Diagnostics Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed